Cephalon, Inc.
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1987-01-01
- Employees
- 3.7K
- Market Cap
- -
- Website
- http://www.cephalon.com
Clinical Trials
47
Trial Phases
4 Phases
Drug Approvals
2
Clinical Trials
Distribution across different clinical trial phases (22 trials with phase data)• Click on a phase to view related trials
The Nuvigil and Provigil Pregnancy Registry
- Conditions
- NarcolepsyObstructive Sleep ApneaShift Work Sleep Disorder
- Interventions
- Drug: Modafinil/armodafinil
- First Posted Date
- 2013-02-15
- Last Posted Date
- 2024-02-05
- Lead Sponsor
- Cephalon, Inc.
- Target Recruit Count
- 191
- Registration Number
- NCT01792583
- Locations
- 🇺🇸
Teva Pregnancy Registry, West Chester, Pennsylvania, United States
A Long-Term Study of the Safety and Tolerability of Repeated Administration of CEP-33457 in Participants With Systemic Lupus Erythematosus
- First Posted Date
- 2010-11-15
- Last Posted Date
- 2022-12-30
- Lead Sponsor
- Cephalon, Inc.
- Target Recruit Count
- 136
- Registration Number
- NCT01240694
- Locations
- 🇺🇸
Teva Investigational Site 27, Birmingham, Alabama, United States
🇺🇸Teva Investigational Site 20, Tucson, Arizona, United States
🇺🇸Teva Investigational Site 16, Los Angeles, California, United States
A Study to Evaluate the Efficacy and Safety of CEP-33457 in Participants With Systemic Lupus Erythematosus (SLE)
- First Posted Date
- 2010-06-02
- Last Posted Date
- 2022-12-16
- Lead Sponsor
- Cephalon, Inc.
- Target Recruit Count
- 183
- Registration Number
- NCT01135459
- Locations
- 🇺🇸
Teva Investigational Site 27, Birmingham, Alabama, United States
🇺🇸Teva Investigational Site 20, Tucson, Arizona, United States
🇺🇸Teva Investigational Site 16, Los Angeles, California, United States
Study to Evaluate the Safety, Tolerability, and Efficacy of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury
- First Posted Date
- 2009-09-24
- Last Posted Date
- 2021-12-17
- Lead Sponsor
- Cephalon, Inc.
- Target Recruit Count
- 49
- Registration Number
- NCT00983437
- Locations
- 🇺🇸
Teva Investigational Site 58, Birmingham, Alabama, United States
🇺🇸Teva Investigational Site 62, Tucson, Arizona, United States
🇺🇸Teva Investigational Site 16, Hot Springs, Arkansas, United States
Study to Evaluate the Efficacy and Safety of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury
- First Posted Date
- 2009-05-06
- Last Posted Date
- 2021-12-17
- Lead Sponsor
- Cephalon, Inc.
- Target Recruit Count
- 117
- Registration Number
- NCT00893789
- Locations
- 🇺🇸
Teva Investigational Site 58, Birmingham, Alabama, United States
🇺🇸Teva Investigational Site 62, Tucson, Arizona, United States
🇺🇸Teva Investigational Site 40, Tucson, Arizona, United States
- Prev
- 1
- 2
- Next